MedPath
NMPA Approval

Cetuximab N01 Injection

国药准字S20250006

January 24, 2025

Drug Information

西妥昔单抗N01注射液

注射剂

100mg(50ml)/瓶

生物制品

January 24, 2025

Company Information

Applicant Company

四川省成都市温江区成都海峡两岸科技产业开发园区新华大道666号

Manufacturing Company

成都市温江区成都海峡两岸科技产业开发园区新华大道666号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

西妥昔单抗N01注射液 - NMPA 批准文号 | MedPath